Exparel Injection Effect on Postoperative Opioid Usage
Part of paid clinical trials in Columbia, Missouri.
- Sponsor
- University of Missouri-Columbia
- Study ID
- NCT04085913
- Phase
- EARLY_PHASE1
- Status
- Enrolling By Invitation
Conditions
- Parathyroid Adenoma
- Thyroid
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Lidocaine Epinephrine — DRUGPreincision injection, as is current practice
- Bupivacaine Hydrochloride-EPINEPHrine — DRUGPreincision injection
- Lidocaine Epinephrine, Bupivacaine Hydrochloride-EPINEPHrine — DRUGPreincison injection of lidocaine and epinephrine and a postincision injection of Exparel
Study Details
The question proposed by this study, is one of patient outcomes. Does intraoperative injection of Exparel decrease postoperative use of opioid pain medications in patients undergoing thyroid and parathyroid surgery? The trial seeks to assess the effect that Exparel has on postoperative pain control.
Key Dates
- Start date
- Sep 30, 2019
- Status verified
- Jul 2024
- Primary completion
- Jun 6, 2024
- Completion
- Jul 31, 2025
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Current PracticeThyroid or parathyroid surgery with local injection of lidocaine and epinephrine preincision, as is current practice.
- Experimental: Bupivicaine HCLThyroid or parathyroid surgery with local injection of bupivicaine HCL and Epinephrine preincision.
- Experimental: Exparel InjectionThyroid and parathyroid surgery with local injection of lidocaine and epinephrine preincison and Exparel postincision
Primary Outcome Measure
Incidence of opioid use when given Exparel intraoperatively [ Time Frame: After surgery, patients will be monitored for two weeks, until they return for their first postoperative appointment. ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Missouri | Columbia | Missouri | 65212 | - |
Find similar trials in Columbia, MO
By research site
Related Studies
- Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint InhibitorsRecruiting · Icahn School of Medicine at Mount Sinai · New York, New York
- Measuring Symptom Relief After Radiofrequency Ablation of the ThyroidEnrolling By Invitation · Mayo Clinic · Rochester, Minnesota
- A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid CancerRecruiting · Memorial Sloan Kettering Cancer Center · New York, New York
- 99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CTPHASE2/PHASE3 · Recruiting · Andrei Iagaru · Stanford, California